| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President and CEO
1 company
Thomas Andrew Crockett last filed a Form 4 in February 2024, as CEO at KALV. From November 2016 to February 2024, the filings on record show 0 open-market purchases and 28 sales. Thomas Andrew Crockett's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Thomas Andrew Crockett's trades have earned a strong insider score of 72/100 across 17 rated trades. Over a 12-month horizon, 70.6% of those trades were profitable, with an average 12-month return of +19.3%.
At the last filing, the largest reported position was 211,203 shares of KALV. The KALV filings lean toward selling, a net 323,156 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2020 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 1,261 | $17.01 | $21,444.06 | -0.5% | |
| Feb 5, 2020 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 200 | $17.05 | $3,410.00 | - | |
| Dec 20, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 2,300 | $17.02 | $39,150.37 | -1.0% | |
| Dec 16, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 7,700 | $17.06 | $131,352.30 | -3.1% | |
| Jul 15, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $17.04 | $170,407.00 | -3.9% | |
| Apr 15, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $24.80 | $247,957.72 | -3.7% | |
| Mar 14, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 3,000 | $30.16 | $90,483.90 | -1.1% | |
| Jan 14, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $19.33 | $193,328.29 | -3.6% |